Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
226 Checkpoint blockade hastens a switch from an NKT dominant, TNF-alpha-driven to a CD4+/CD8+ IFN-gamma-driven immune response within MC-38 tumor-infiltrating lymphocytes
Compose a Response to This Article
Other responses
No responses have been published for this article.
